Akums Drugs and Pharmaceuticals IPO Subscription Status: Akums Drugs and Pharmaceuticals IPO is Open on 30 July, 2024 and Close on 1 August, 2024. Akums Drugs and Pharmaceuticals IPO to Raise 27,345,162 shares (Appprox ₹1,856.74 Cr) via IPO. The Fresh Issue of 10,014,727 shares (Approx ₹680.00 Cr) and The Offer For the Sale is 17,330,435 shares of ₹2 (Approx ₹1,262.83 Cr).
- The Retail Quota is 10%
- QIB is 75%
- NII is 15%
Akums Drugs and Pharmaceuticals IPO is an Mainline IPO and Listed on NSE & BSE. Akums Drugs and Pharmaceuticals IPO Price Band is Fixed at ₹646 to ₹679 Equity Share. Akums Drugs and Pharmaceuticals IPO Lot Size is 22 Shares.
About Akums Drugs and Pharmaceuticals IPO :
- Akums Drugs and PharmaceuticalsEstablished in 2004, we are a pharmaceutical contract development and manufacturing organization (“CDMO”) offering a comprehensive range of pharmaceutical products and services in India and overseas. As one of the leading CDMOs in India, we own the intellectual property for the manufacturing processes of several of our formulations, and our core business is focused on providing end-to-end product development and manufacturing solutions to our clients.
- Some of our other services include formulation research and development (“R&D”), preparation and filing of regulatory dossiers in the Indian and global markets, and other testing services. In addition to our core CDMO business. we are also engaged in the manufacturing and sale of branded pharmaceutical formulations and active pharmaceutical ingredients (“APIs”)
Also Read: Akums Drugs and Pharmaceuticals IPO Details Today, GMP Price, Date, Review
Akums Drugs and Pharmaceuticals IPO Subscription Status, Rate bid times
Inv Category
Shares Reserved
No. of Shares bid for
No. of Times (Subscription)
Qualified Buyers (QIBs)
81,37,276
73,31,17,770
90.09
Non Institutional Buyers (NIIs)
40,68,637
17,13,07,510
42.08
BNII
27,12,425
12,86,49,664
47.43
SNII
13,56,212
4,26,57,846
31.45
Retail Individual Buyers (RIIs)
27,12,424
5,64,23,114
20.57
Anchor Investor
1,22,05,912
1,22,05,912
1
Employee
2,43,902
5,50,308
4.14
Total
1,51,62,239
96,18,57,204
63.40
Akums Drugs and Pharmaceuticals Subscription Status day-by-day-
Categories
30 July
31 Juy
1 August
QIB
0.43
0.96
90.09
NII
1.97
8.51
42.08
RII
3.38
9.08
20.57
EMP
1.11
2.26
4.14
Total
1.40
4.46
63.40
Akums Drugs and Pharmaceuticals Investor Categories
- Qualified Institutional Buyers (QIB).
- Non- Institutional Investors (NII).
- Retail individual Investors (RII).
- Employee (EMP).
- Others (Eligible Shareholders).
Who Is QIB In IPO?
QIB Stands For “Qualified Institutional Buyer” In The Context Of An IPO (Initial Public Offering). QIBs Are A Category Of Institutional Investors Who Are Considered Financially Sophisticated And Meet Certain Regulatory Criteria For Participating In Capital Markets. In The Context Of An IPO, QIBs Play A Significant Role As They Contribute To The Overall Demand For Shares And Help Determine The Success Of The Offering.
Who Is NII In IPO?
NII Stands For “Non-Institutional Investors” In The Context Of An IPO (Initial Public Offering). Non-Institutional Investors Are A Category Of Investors Who Participate In The IPO Alongside Institutional Investors And Retail Investors. NII Typically Includes High Net Worth Individuals (HNIs), Corporate Bodies, Trusts, And Other Entities That Are Not Classified As Institutional Investors But Have The Financial Capacity To Invest Significant Amounts In The IPO.
Who Is RII In IPO?
RII Stands For “Retail Individual Investor” In The Context Of An IPO (Initial Public Offering). Retail Individual Investors Are Individual Investors Who Participate In The IPO Alongside Institutional Investors And Non-Institutional Investors. RII Typically Includes Individual Investors Who Do Not Meet The Criteria To Be Classified As Institutional Investors Or Non-Institutional Investors.
Who Is EMP In IPO?
“EMP” In The Context Of An IPO (Initial Public Offering) Typically Stands For “Employee.” In Some IPOs, A Certain Portion Of The Shares May Be Reserved For Allocation To Employees Of The Company Going Public. These Employees Are Often Referred To As “Employee Shareholders” Or “Employee Participants” (EMP).
Akums Drugs and Pharmaceuticals Review From MoneyMintIdea –
- May Apply
